Literature DB >> 29244073

Incidence of infective endocarditis among patients considered at high risk.

Lauge Østergaard1, Nana Valeur2, Nikolaj Ihlemann1, Henning Bundgaard1, Gunnar Gislason3,4, Christian Torp-Pedersen5,6, Niels Eske Bruun7,8, Lars Søndergaard1, Lars Køber1, Emil Loldrup Fosbøl1.   

Abstract

Aims: Patients with prior infective endocarditis (IE), a prosthetic heart valve, or a cyanotic congenital heart disease (CHD) are considered to be at high risk of IE by guidelines. However, knowledge is sparse on the relative risk of IE between these three groups and compared controls. Methods and results: Using Danish nationwide registries (1996-2015), we identified all patients with prior IE, a prosthetic heart valve, or a complex CHD (defined as tetralogy of Fallot, truncus arteriosus, and transposition of great arteries) as well as matched control populations. Patients were followed up until death, end of study period, IE hospitalization, emigration, or a maximum of 10 years of follow-up, whichever came first. Multivariable adjusted Cox proportional hazard analysis was used to compare the risk of IE between the study groups and the matched controls. We included 25 945 patients: 5096 had prior IE, 19 478 had a prosthetic heart valve, and 1371 had complex CHD. The cumulative risk of IE at 10 years of follow-up was 8.8%, 6.0%, and 1.3% for patients with prior IE, a prosthetic valve, and complex CHD, respectively. Patients with prior IE and a prosthetic valve had a significant increased associated risk of IE compared with the matched controls [hazard ratio (HR) 65.4, 95% confidence interval (CI) 43.1-99.1 and HR 19.1, 95% CI 15.0-24.4), respectively]. No events occurred among the matched controls for the complex CHD group and an HR could not be calculated.
Conclusion: All IE high-risk groups carried a higher risk of IE than the matched controls from the general population. These results justify the European and American guidelines in considering these groups at high risk of IE. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2017. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Congenital heart disease; Heart valve surgery ; High-risk population; Incidence; Infective endocarditis

Mesh:

Year:  2018        PMID: 29244073     DOI: 10.1093/eurheartj/ehx682

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  13 in total

1.  Echocardiographic findings in patent ductus arteriosus-associated infective endarteritis.

Authors:  Huitzilihuitl Saucedo-Orozco; Jesús Vargas-Barrón; Clara A Vázquez-Antona; Francisco Castillo-Castellón
Journal:  Anatol J Cardiol       Date:  2021-11       Impact factor: 1.596

Review 2.  Antibiotic prophylaxis before dental procedures to prevent infective endocarditis: a systematic review.

Authors:  Judith Bergadà-Pijuan; Michelle Frank; Sara Boroumand; Frédérique Hovaguimian; Carlos A Mestres; Robert Bauernschmitt; Thierry Carrel; Bernd Stadlinger; Frank Ruschitzka; Annelies S Zinkernagel; Roger D Kouyos; Barbara Hasse
Journal:  Infection       Date:  2022-08-16       Impact factor: 7.455

3.  Incidence of infective endocarditis during the coronavirus disease 2019 pandemic: A nationwide study.

Authors:  Eva Havers-Borgersen; Emil L Fosbøl; Jawad H Butt; Jeppe K Petersen; Andreas Dalsgaard; Frederik Kyhl; Morten Schou; Matthew Phelps; Kristian Kragholm; Gunnar H Gislason; Christian Torp-Pedersen; Lars Køber; Lauge Østergaard
Journal:  Int J Cardiol Heart Vasc       Date:  2020-11-06

4.  Infective endocarditis after transcatheter aortic valve implantation: a nationwide study.

Authors:  Henrik Bjursten; Magnus Rasmussen; Shahab Nozohoor; Mattias Götberg; Lars Olaison; Andreas Rück; Sigurdur Ragnarsson
Journal:  Eur Heart J       Date:  2019-10-14       Impact factor: 29.983

5.  Pre-implant screening guided by cardiac silhouette fluoroscopy: a way to increase eligibility for the subcutaneous implantable cardioverter-defibrillator: a case report.

Authors:  Victoria Galizia Brito; Aina Bibiloni Cladera; Maria Del Carmen Exposito Pineda; Carlos Grande Morales
Journal:  Eur Heart J Case Rep       Date:  2020-12-29

6.  Mechanical Thrombectomy for Acute Ischemic Stroke Caused by Prosthetic Aortic Valve Endocarditis Due to Exophiala dermatitidis Infection: A Case Report.

Authors:  Ryo Hiruta; Naoki Sato; Toshihito Ishikawa; Katsuhiro Endo; Yuji Endo; Haruhiko Kikuta; Mudathir Bakhit; Takao Kojima; Masazumi Fujii; Mamoru Ota
Journal:  NMC Case Rep J       Date:  2021-12-22

7.  Incidence of Infective Endocarditis Among Patients With Tetralogy of Fallot.

Authors:  Eva Havers-Borgersen; Jawad H Butt; Morten Smerup; Gunnar H Gislason; Christian Torp-Pedersen; Mathis Gröning; Michael Rahbek Schmidt; Lars Søndergaard; Lars Køber; Emil L Fosbøl
Journal:  J Am Heart Assoc       Date:  2021-11-03       Impact factor: 5.501

8.  Surgical treatment of valve endocarditis in high-risk patients and predictors of long-term outcomes.

Authors:  Giuseppe Nasso; Giuseppe Santarpino; Marco Moscarelli; Ignazio Condello; Angelo Maria Dell'Aquila; Armin Darius Peivandi; Mario Gaudino; Flavio Fiore; Pasquale Mastroroberto; Nicola Di Bari; Giuseppe Speziale
Journal:  Sci Rep       Date:  2021-12-20       Impact factor: 4.379

Review 9.  Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice.

Authors:  Alessio Buonavoglia; Patrizia Leone; Antonio Giovanni Solimando; Rossella Fasano; Eleonora Malerba; Marcella Prete; Marialaura Corrente; Carlo Prati; Angelo Vacca; Vito Racanelli
Journal:  Antibiotics (Basel)       Date:  2021-05-09

10.  Proposal for the use of echocardiography in bloodstream infections due to different streptococcal species.

Authors:  Sandra Chamat-Hedemand; Niels Eske Bruun; Lauge Østergaard; Magnus Arpi; Emil Fosbøl; Jonas Boel; Louise Bruun Oestergaard; Trine K Lauridsen; Gunnar Gislason; Christian Torp-Pedersen; Anders Dahl
Journal:  BMC Infect Dis       Date:  2021-07-16       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.